Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Orthofix Medical Inc.NASDAQ: OFIX

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 40.45M shares rose 3.2% year over year, in line with the +3.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 1.1% from the prior quarter. Over 3 fiscal years it compounded at +25.7% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +3.2% toward the trailing-twelve-month pace of +3.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
40.45M+1.1% QoQ
Last fiscal yearDec 2025
39.88M+4.6% YoY
LTMMar 2026
39.93M+3.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.2%——
1 year+4.6%——
3-year CAGR+25.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
39.88M USD
Year-over-year change
+4.6%
4-year CAGR
+19.3%

Weighted Avg Shares (Diluted) vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 weighted avg shares (diluted) of 39.93M shares is the lowest of the 11 companies compared; the peer median is 104.67M shares.
  • Its year-over-year change of +3.4% is the 8th highest of 11, against a peer median of +4.6%.
  • Over three fiscal years its annual growth of +25.7% compares with a peer median of +12.4%.
OFIX Competitors Peer median
Weighted Avg Shares (Diluted) for OFIX and competitors
Company Period LTM YoY 3-year CAGR
LABStandard BioTools Inc.LTM Mar 2026384.09M +2.7%+69.5%
PACBPacific Biosciences of California, Inc.LTM Mar 2026302.18M +5.2%+10.1%
BFLYButterfly Network, Inc.LTM Mar 2026250.79M +15.2%+7.3%
ESPREsperion Therapeutics, Inc.LTM Mar 2026232.73M +20.1%+46.3%
ABSIAbsci CorporationLTM Mar 2026143.73M +23.4%+14.6%
MLTXMoonLake ImmunotherapeuticsLTM Mar 202665.6M +4.1%+30.0%
DRIODarioHealth Corp.LTM Mar 202649.63M +19.8%+28.1%
AVNSAvanos Medical, Inc.LTM Mar 202646.5M +0.2%-0.6%
SIBNSI-BONE, Inc.LTM Mar 202643.36M +3.6%+8.4%
VREXVarex Imaging CorporationLTM Apr 202641.88M -3.9%-0.2%
OFIXOrthofix Medical Inc.LTM Mar 202639.93M +3.4%+25.7%
Peer median (excluding OFIX) 104.67M+4.6%+12.4%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue464.48M460.71M746.64M799.49M822.31M
Cost of Revenue114.91M123.54M260.37M253.61M270.61M
Gross Profit349.57M337.17M486.27M545.89M551.71M
Gross Margin75.3%73.2%65.1%68.3%67.1%
Research & Development49.62M49.07M80.23M73.64M57.11M
Selling, General & Admin290.67M308.78M530.4M532.53M456.39M
Operating Expenses357.88M350.44M625.38M630.5M620.18M
Depreciation & Amortization33.1M32.08M60.56M60.06M50.97M
EBITDA21.44M15.66M(79.49M)(34.18M)(22.35M)
EBITDA Margin4.6%3.4%-10.6%-4.3%-2.7%
Operating Income(8.32M)(13.27M)(139.11M)(84.62M)(68.47M)
Operating Margin-1.8%-2.9%-18.6%-10.6%-8.3%
Interest Income00000
Interest Expense1.84M1.29M8.63M29.63M17.49M
Other Income / Expenses(5.18M)(4.44M)(9.57M)(39.26M)(22.34M)
Income Before Tax(13.5M)(17.71M)(148.68M)(123.88M)(90.81M)
Pre-Tax Margin-2.9%-3.8%-19.9%-15.5%-11.0%
Income Tax Expense24.88M2.04M2.72M2.12M1.38M
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Net Margin-8.3%-4.3%-20.3%-15.8%-11.2%
EPS (Basic)(1.95)(0.98)(4.12)(3.30)(2.28)
EPS (Diluted)(1.95)(0.98)(4.12)(3.30)(2.28)
Weighted Avg Shares19.69M20.1M36.73M38.13M39.88M
Weighted Avg Shares (Diluted)19.69M20.1M36.73M38.13M39.88M

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.